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Abstract
Background: Chromothripsis, a newly discovered type of complex genomic rearrangement, has been implicated in
the evolution of several types of cancers. To date, it has been described in bone cancer, SHH-medulloblastoma and
acute myeloid leukemia, amongst others, however there are still no formal or automated methods for detecting or
annotating it in high throughput sequencing data. As such, findings of chromothripsis are difficult to compare and
many cases likely escape detection altogether.
Results: We introduce ShatterProof, a software tool for detecting and quantifying chromothriptic events.
ShatterProof takes structural variation calls (translocations, copy-number variations, short insertions and loss of
heterozygosity) produced by any algorithm and using an operational definition of chromothripsis performs robust
statistical tests to accurately predict the presence and location of chromothriptic events. Validation of our tool was
conducted using clinical data sets including matched normal, prostate cancer samples in addition to the colorectal
cancer and SCLC data sets used in the original description of chromothripsis.
Conclusions: ShatterProof is computationally efficient, having low memory requirements and near linear
computation time. This allows it to become a standard component of sequencing analysis pipelines, enabling
researchers to routinely and accurately assess samples for chromothripsis. Source code and documentation can be
found at http://search.cpan.org/~sgovind/Shatterproof.
Keywords: Chromothripsis, Complex genomic rearrangement, Next generation sequencing, High throughput
sequencing, Perl, Bioinformatics
Background
Chromothripsis is a type of complex genomic rear-
rangement first characterized in 2011 [1]. Stephens
et al. described a phenomenon wherein a chromosome
appeared to shatter into hundreds of pieces, then hap-
hazardly stitch itself back together. The resulting chromo-
somes possess a very high number of structural variations
(SVs) including duplications, deletions and translocations
[1]. The most striking feature of these derivative chromo-
somes is pronounced clustering of translocations and copy
number aberrations to specific regions.
*Correspondence: Paul.Boutros@oicr.on.ca
1Ontario Institute for Cancer Research, M5G 0A3, Toronto, Canada
5Department of Medical Biophysics, University of Toronto, Toronto, Ontario,
Canada
Full list of author information is available at the end of the article
The exact mechanisms driving chromosome shat-
tering remain unknown, however aberrant mitosis
producing micronuclei [2] and premature chromosome
compaction (PCC) [2,3] have been implicated. Similarly,
the mechanisms driving the stitching process have yet
to be determined, but recent work suggests that DNA
repair mechanisms such as non-homologous end joining
(NHEJ), fork stalling and template switching (FoSTeS)
and micro-homology mediated break induced repair
(MMBIR) are involved [4,5].
Recent genome sequencing studies have identified sev-
eral classes of complex genomic rearrangements that
appear to be derived from a single catastrophic event
rather than numerous incremental steps. In [6], Zhang
et al. discuss these phenomena, summarize current mod-
els, and consider the impact of massive chromosomal
© 2014 Govind et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited.
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change on the development of diseases such as cancer.
Since the evolutionary processes that cause chromothrip-
sis are unique, it is likely that chromothriptic genomes
produce phenotypes quite distinct from genomes whose
SVs arise gradually over time. As such, identifying patients
with signs of chromothripsis may lead to improvements
in classification and thus help guide clinical decision
making.
Studies have indicated that there exists a certain amount
of heterogeneity with respect to the genotypes of genomes
resulting from chromothripsis. The complexity of the
variations found in chromothriptic genomes vary some-
what between reported cases, however studies have also
revealed a set of hallmark characteristics that are present
in almost all cases, including:
1. Localization of structural variations to a few
chromosomes [1,7]
2. Localization of structural variations within a
chromosome to a specific region (e.g. the distal arm
or telometric region [1,4])
3. A low number of copy-number states, usually only
two. Typically, one of these is the normal copy
number (CN) state and the other is a deletion state
indicating fragments of the genome that have been
lost [1]
4. A high number of transitions from the normal
copy-number state to the aberrant one [1]
5. In regions of normal copy-number, heterozygosity is
preserved [1,3,4]
6. Chromosomal translocations demonstrate a high
level of clustering in particular regions [1-4,7]
7. Short insertions at translocation breakpoints
[1,3,4,7], indicative of both NHEJ and MMBIR (not
clear if these are template or non-template insertions)
8. The TP53 gene is nonsynonymously mutated [3]
These hallmarks have been discovered in 2%-3% of all
cancers [8] and in approximately 25% of bone cancers [1].
More recent investigations have discovered chromoth-
ripsis in medulloblastomas [9], acute myeloid leukemia
[3], in 5% of prostate cancers [8,10] and in 18% of neu-
roblastomas [11]. Additionally, chromothripsis has been
discovered in the germ lines of a number of individu-
als suffering from developmental and congenital defects
[12,13]. Thus far, chromothripsis has been primarily iden-
tified using ad hoc methods which annotate a chromo-
some as having undergone chromothripsis if one or two
of the chromothriptic hallmarks are detected. However,
these methods are only employed after chromosomes are
identified to be suspicious, typically by visual inspection.
Additionally, the criteria used to annotate a chromothrip-
tic event vary between investigators, making comparisons
cumbersome and casting doubts on relative frequency
statistics. As such, there is an urgent need for standard-
ized and unbiased metrics to quantify chromothriptic
events.
We present a new approach, called ShatterProof, that
aims to address these shortcomings. ShatterProof enables
the efficient identification and quantification of chro-
mothriptic events in next-generation sequencing data
without the need to pre-screen for suspicious samples.
ShatterProof quantifies the degree to which chromoth-
riptic hallmarks are expressed. The precise definition of
chromothripsis including all of its features remains a con-
tentious topic and until a single clear definition is decided
upon, analyzing sequencing data with respect to the cur-
rent set of hallmarks will enable further investigation and
improved detection.
When provided with SV calls from next generation
sequencing data, ShatterProof generates metrics describ-
ing each of the chromothriptic hallmarks and analyzes
these to identify locations in the genome where chro-
mothriptic events have most likely occurred.
A standardized report that is both human readable and
machine parseable is created. This report contains all of
themetrics and probability values for potential chromoth-
riptic events, enabling easier analysis and comparison
across studies.
Implementation
ShatterProof is implemented as a Perl module that pro-
cesses input files and produces output files in both tab-
delimited and YAML format [14]. Perl version 5.10 or
greater is required. ShatterProof was designed to be highly
modular. This allows for sub-methods to be easily re-used
and enabled robust testing of all stages of the pipeline.
Additionally, due to the very large range of input values,
many design decisions focused on error-resilience. Pre-
and post-condition checking were employed to ensure
correctness of calculations and processing. Unit and
regression testing consisting of 65 test cases ensure that
correct behaviour of input parsing and score-generating
methods is maintained.
Input and workflow
ShatterProof bases its analysis of genomic data on calls
of SVs, including translocations, copy number variations
(CNV), loss of heterozygosity (LOH) and short insertions.
Currently, there is no gold standard tool for producing any
of these. Accordingly, ShatterProof has been designed to
work with output produced by any SV tool. In this way
ShatterProof will always be able to leverage the improv-
ing capabilities of newer identification tools in a seamless
way. Because different tools produce output in a differ-
ent format, ShatterProof requires that these be converted
into simple tab delimited input file formats that contain
only the information needed for chromothriptic analysis.
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Input file formats were specified for each type of SV that
would be analyzed: translocations, CNVs, LOH events and
short insertions. Scripts to convert the output of some
common SV tools to the input file formats required by
ShatterProof are provided with the ShatterProof distri-
bution. Translocations are recorded in .spt files which
contain the following fields:
1. source chromosome
2. start position on source chromosome
3. end position on source chromosome
4. destination chromosome
5. start position on destination chromosome
6. end position on destination chromosome
7. quality of the call (value between 0 and 1)
CNVs are recorded in .spc files which contain the fol-
lowing fields:
1. chromosome
2. start position
3. end position
4. copy number
5. quality of the call (value between 0 and 1)
LOH events are recorded in .spl files which contain the
following fields:
1. chromosome
2. start position
3. end position
4. quality of the call (value between 0 and 1)
Additionally, ShatterProof accepts insertion calls in VCF
version 4.0 [15] files. ShatterProof analyzes the CHROM,
POS, REF, and ALT fields of these files.
Examples of each input file format can be seen in
Additional file 1.
Figure 1 illustrates the ShatterProof work flow that pro-
duces the data structures containing the processed input
data. ShatterProof will generate the most accurate results
if all four types of input files are provided, but can accom-
modate significant missing input data: only translocations
and CNVs are required.
The data structures containing the SV calls, produced
from parsing the input files, are then subjected to a slid-
ing window analysis to compute metrics of SV density
across the genome. The size of the sliding window is a user
definable parameter. A smaller window increases base pair
resolution but also increases running time and total mem-
ory consumption. A default window size of 10Mbp where
each window overlaps with the previous one on 9.99Mbps
was selected as it produced calls with useful resolution in
a reasonable running time (see Performance for details).
The metrics produced from the sliding window analysis
are used to identify highly mutated regions by comparing
region-specific SV density to genome-wide density using
a z-scale approach. A chromothripsis score is then calcu-
lated for each highly mutated region as outlined below.
Scoring
For each highly mutated region, a numerical score
between 0 and 1 is calculated to indicate the likelihood
that chromothripsis has occurred. This score is:
N∑
n=1
(hallmark weightn)(hallmark scoren) (1)
Where, N is the total number of hallmarks,
hallmark weightn is a numerical representation of how
significantly the hallmark indicates chromothripsis
(described below) and hallmark scoren is a measure of the
degree to which the region exhibits this hallmark.
Hallmark weights
Certain hallmarks are more indicative of chromothripsis
than others. For example, the localization of transloca-
tions and CNVs to a specific region in the chromosome is
a stronger indicator than is the presence of a TP53 muta-
tion or the presence of short insertions at translocation
breakpoints. Indeed, localization of translocations and
CNVs to a specific region of a chromosome was found in
all cases of chromothripsis whereas this was not the case
for the TP53 mutations [1,3]. To account for the varying
significance of hallmarks when generating the chromoth-
ripsis score, multi-criteria analysis (MCA) [16] was used
to calculate hallmark weightings. This process produces
values that quantify the relative importance of qualitative
attributes. LibreOffice (v3.5.4.2) was used to perform the
MCA calculations (see Additional file 2 for source spread-
sheet). Intermediate values can be found in Appendix A
(Additional file 3). The resulting weights are shown in
Table 1.
The value of these weightings can be user customized
depending on the relative quality of input data that is
being given to ShatterProof. For example, if very high
quality translocation calls are produced, a user can choose
to increase theweight of the translocation hallmark so that
it makes a larger contribution to the final score.
Hallmark scores
ShatterProof calculates hallmark scores for each highly
mutated region by performing statistical analysis on the
SV data for that region. Each score is in [0,1], where 1
indicates that the hallmark is strongly represented in the
region and 0 indicates the hallmark is not represented at
all. Figure 2 illustrates the ShatterProof work flow that
produces the hallmark and final chromothripsis scores
for each highly mutated region. The following sections
describe the equations used to calculate the score for each
chromothriptic hallmark.
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Figure 1 ShatterProof input parsing workflow. Original output from existing tools is converted to the ShatterProof input file formats using
scripts. ShatterProof then reads and parses the data in these input files into efficient data structures.
Genome localization
The density of SVs in each chromosome is determined
by summing the number of translocations breakpoints
and CNV breakpoints, scaled by the total chromosome
length. A translocation breakpoint is defined as one end
of a translocated region, therefore all translocations are
comprised of four breakpoints, two from the originating
Table 1 MCA calculatedhallmark weights
Hallmark Weighting
Genome localization 0.1145
Chromosome localization 0.1697
Copy-number aberrations 0.2724
Translocation localization 0.2724
Retention of heterozgosity 0.0648
Presences of insertions at translocation breakpoints 0.0657
Presences of TP53 mutations 0.0406
Sum: 1.0000
chromosome and two from the destination chromosome.
A CNV breakpoint is defined as one end of an ampli-
fied or deleted region, therefore all CNVs are comprised
of two breakpoints. If translocations or CNVs occurs at
the end of a chromosome (e.g. loss of chromosome arm) a
breakpoint is inserted after the last base pair of the chro-
mosome. If a SV occurs at the start of a chromosome,
a breakpoint is placed before the first base pair of the
chromosome. The genome localization score for a highly
mutated region is calculated from the z-score for the SV
density of the chromosome in which it is found. This
z-score is converted to a right-tailed p-value via the stan-
dard normal distribution, giving a genome localization
score as:
Genome Localization Score = 0.5− p0.5 (2)
To avoid multiple-testing, scores will only be calculated
for chromosomes whose SV density is greater than the
mean of all chromosomes, resulting in z-scores always
being greater than 0. As such, the right-tailed p-value (p)
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Figure 2 Suspect region identification and score calculation. Once ShatterProof has parsed all input data, a sliding window analysis identifies
genomic regions which are heavily mutated. Note that the window size is user definable. ShatterProof then produces a chromothripsis score for
each of these regions, by analyzing all SV data corresponding to it. The analysis produces hallmark scores which represent how significantly the
region exhibits each hallmark,which are then scaled by their respective MCA weighting and summed to produce a chromothripsis score.
will have a maximum value of 0.5 and a minimum value
of 0. A genome localization score near 1 (resulting from
a high z-score) indicates that the SV density of the sus-
pect chromosome is much greater than the mean of the
SV densities of all the chromosomes, and a score near 0
(resulting from a low z-score) indicates that the SV den-
sity of the suspect chromosome is close to the mean and
thus is insignificant.
Chromosome localization
To calculate the chromosome localization score for a
highly mutated region, the SV density of the region is
compared to the overall SV density of the chromosome
using Pearson’s chi-squared test with one degree of free-
dom. The test statistic is calculated as:
χ2 = (SV Densityregion − SV Densitychromosome)
2
SV Densitychromosome
(3)
Low number of copy-number states and high number of
copy-number state oscillations
Chromothripsis is characterized by a low number of dif-
ferent aberrant CN states and a high number of CN state
oscillations [1,5,6]. To quantify this, a higher CNV score
is given to regions that have only one or two aberrant
CN states and a high density of CN state oscillations. For
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example, a regionwith 3 different aberrant CN states, each
contributing 5 CN state oscillations to the region, would
receive a lower CNV score than a region with only 1 aber-
rant CN state that contributed 15 CN state oscillations. To
achieve this sensitivity, we calculate:
CNV Score =
( 1
Nsignificant
)
⎛
⎜⎜⎝1− 1
1+ log2(
∑Nsignificant
n=1 c2n
Nsignificant )
⎞
⎟⎟⎠
(4)
Nsignificant is determined from the standard deviation of
the number of regions at each aberrant CN level. The z-
score for each value is then calculated and Nsignificant is set
to the number of values that have a z-score greater than -2
(this is user definable). This is done to filter noisy calls that
incorrectly add CN states to the region. As such, the first
term in the equation reduces the aberrant CN score as the
number of CN states that contribute a significant num-
ber of events increases. The second term increases the
aberrant CN score as the number of region contributed
by significant CN states increases and gives more power
to CN state oscillations contributed by a single CN state
versus those contributed by many CN states.
Translocation localization
The equations that are used to calculate this hallmark
score aim to give a high score to regions that have a high
number of localized translocations and give a low score
to regions with only a few translocations that are not
localized. For each highly mutated region, chromosomes
involved in a translocation with the region are identified
and, for each of these, a list of translocation breakpoints
is generated. For example, if in a highly mutated region
found in chromosome 3 there exists an inserted frag-
ment that matches a sequence in chromosome 1, then the
breakpoints on chromosome 1 that delimit the translo-
cated fragment will be recorded. Additionally, if in the
same highly mutated region there exists a sequence that
matches an inserted fragment on chromosome 2, then
the breakpoints on chromosome 2 that delimited this
fragment will be recorded. The translocation score is then:
spread =
∑C
i=1 bi+1 − bi
C (5)
spread factor = log(1+ spreadn)−log(expected spread) (6)
weighted sum =
Nsig∑
n=1
( c2n
(spread factor)(cT )
)
(7)
Translocation Score = (1− 0.10(Nsignificant − 2))
×
(
1− 1log2(1+ weighted sum)
) (8)
The value of Nsignificant in equation (8) indicates the
number of chromosomes that share a significant number
of translocation with the highly mutated region.Nsignificant
is determined by calculating the standard deviation of the
number of translocations between each chromosome and
the region, and then calculating the z-score of each value.
Nsignificant is the number of z-scores that are greater than
a user definable value. By default this value is -2, which
serves to remove the chromosomes with translocation
counts in the bottom 3% of all the counts. This prevents
low-value outliers from over influencing the transloca-
tion score. If Nsignificant is greater than 8 (a user-definable
parameter) then the value of the first term in equation
(8) and thus the entire translocation score is set to 0.
The default cut-off value of 8 reflects our observation
that most documented cases of chromothripsis only had
translocation between a small number of chromosomes. If
the value of Nsignificant is 1 then the value of the first term
is set to 1.
The second term in equation (8) increases the score
as the total number of translocations to or from the
highly mutated region increases. The weighted sum is a
scaled sum of the translocation counts of each signifi-
cant chromosome. This value is calculated in equation (7).
cn is the number of translocations from significant chro-
mosome n and cT is the total number of translocations
from all significant chromosomes. Thus the translocation
count for each chromosome is scaled by the fraction of
the total number of translocations that are contributed
by that chromosome. Additionally, the count from each
chromosome is scaled according to the spread of the
translocation breakpoints along that chromosome. The
larger the spread, the more the translocation count is
reduced and the smaller the spread the greater the count
is amplified. To determine the spread factor, the cal-
culated spread is compared to the expected spread in
equation (6).
The spread for each chromosome is determined by
first calculating the difference between adjacent terms
in an ordered list of the breakpoints on the chromo-
some. These breakpoints correspond only to transloca-
tions that are to or from the highly mutated region.
The standard deviation of the separation values is then
determined and values that are found to have a z-score
greater than 2 (this is a user definable value) are disre-
garded. High-value outliers are removed from the cal-
culation in order to not penalize cases where there are
multiple small groups of localized translocation break-
points, each separated by some relatively large distance.
The spread is then calculated in equation (5) as the
mean of the remaining separation values. The combi-
nation of these equations gives a high score to regions
with very localized translocations between one or two
chromosomes.
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Regions of retained heterozygosity
To calculate the heterozygosity score for a highly mutated
region, ShatterProof first makes an estimate about how
much heterozygosity should remain in the mutated
chromosome. ShatterProof assumes that all the regions
between any CNV are heterozygous, then using any exper-
imental LOH data, it calculates the percentage of pre-
dicted heterozygous regions that overlap with regions of
LOH. The heterozygosity score is:
Heterozygosity Score = 1− Amount of LOH OverlapAmount of Original Heterozygosity
(9)
High LOH overlap indicates a large loss of heterozygos-
ity, resulting in a low score. Limited overlap indicates that
most heterozygosity between CNVs is preserved, resulting
in a high score.
Short insertions at breakpoints
The breakpoint insertion score is calculated by determin-
ing the fraction of translocation breakpoints in a highly
mutated region where short insertions are found within
10 base pairs of the breakpoint.
Short Insertion Score = Number Of Breakpoints With InsertionsTotal Number Of Breakpoints
(10)
The greater the fraction, the higher the score.
TP53 mutations
The TP53 mutation score is simply a 1 or 0 depend-
ing on whether or not the user indicates that a non-
synonymous mutation is present in the TP53 loci. This
feature can be used if TP53 mutations are identified via
non-sequencing techniques(e.g. Immunohistochemistry).
Additionally, ShatterProof will scan input data and deter-
mine if any mutations are present in the 7.57 -7.59 Mbp
region of chromosome 17. If mutations are found, Shatter-
Proof will note in the final output file that TP53mutations
were discovered, however these mutations will not affect
the chromothripsis scores.
Output
ShatterProof produces a number of different output files
which summarize the analysis that it performs. The out-
put files can be divided into three categories: final report,
intermediate data, and TP53 mutations.
The final report file lists the regions where ShatterProof
has found strong indications of chromothripsis. For each
suspect region, the output file contains the chromosome,
start and end position of the region, the chromothripsis
score, and additional statistics about each of the chro-
mothriptic hallmarks. YAML was chosen as the output
format so that it would be both human readable as well
as easily machine parseable. A sample final report file is
shown in Appendix B (Additional file 3).
The intermediate data output files contain:
• the results of the sliding window analysis of the SV
clustering
• the number of CN state oscillations on each
chromosome
• the overall SV density of each chromosome
• a list of the number of aberrant CN states present on
each chromosome
• a list of the number of translocations that occur
between each and every chromosome
Intermediate data output files are tab delimited so that
they can easily be graphed using software such as R or
MATLAB. For example, the data from the sliding window
analysis of a sample chromosome was visualized using R
(Figure 3).
Results
Validation
To validate the accuracy of ShatterProof, we ran the tool
against 21 separate whole-genome sequences (Table 2).
All sequences were aligned using Novoalign (Novocraft
v2.07.14). Translocation calls were produced using Break-
Dancer (v1.1) [17]. Only translocation calls that had a
confidence score greater than 60 were considered. When
running both the pre-processing andmain phase of Break-
Dancer, no command line options were supplied. Control-
FREEC (v5.7) [18] was used to produce CNV calls for all
of the samples. See Additional file 4 for the configuration
file used to run Control-FREEC.
We first ran ShatterProof on 10 normal reference
samples. ShatterProof produced an average of 10 calls
(9 - 12) per sample with a median score of 0.1468
(0.1089 - 0.3667). The low number of calls produced
and their low scores are consistent with the fact that
these samples contain few SVs that are not highly local-
ized. This provides a background distribution for Shatter-
Proof.
Next, we ran ShatterProof against data from the 2 sam-
ples from the Living Tumor Lab (Accession Number:
[SRX147666] and [SRX147668]). Four replicate libraries
were provided for each sample, previously described by
Wu et al. [19]. The samples were found to bear both
the translocation and CNV hallmarks of chromothrip-
sis on chromosomes 4, 8, 12, and 20, with translocation
breakpoints clustered very closely to the CNV breakpoints
resulting in a few localized regions of very high SV density
on those chromosomes. Wu et al. utilized data from both
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Figure 3 Sliding window analysis. Graphing the data from the tab delimited intermediate output files produces plots that visualize the clustering
of SVs along a chromosome. The region highlighted in red was identified by ShatterProof as highly chromothriptic. Note that chromothriptic
regions are not always those with the highest SV density. ShatterProof identifies regions as chromothriptic primarily based on the organization and
clustering of SVs.
RNA and DNA sequencing to produce accurate SV calls
which they then further analyzed to call chromothripsis
[19].
To produce the translocation and CNV calls that were
given to ShatterProof, we provided BreakDancer and
Control-FREEC with DNA sequencing data from each of
the 8 replicate libraries. Running ShatterProof with these
SV calls produced an average of 16 chromothriptic calls
(11 - 21) per replicate with a median score of 0.2797
(0.159 - 0.558). The regions which were scored highest
by ShatterProof, with scores ranging from 0.43 to 0.558,
correspond to those previously identified as highly chro-
mothriptic [19]. Specifically, ShatterProof produced 17
calls with scores greater than 0.43, all of which came from
chromosomes 4, 8, 12, or 20. These results demonstrate
ShatterProof ’s ability to accurately call chromothripsis
from DNA sequencing data alone. See Additional files 5
and 6 for diagrams of translocation and CNV calls.
Table 2 Summary of clinical data
Sample type Source Count Coverage Reference
Normal blood CPCG network 10 30× hg19
Prostate cancer CPCG network 7 50× hg19
Prostate cancer Living tumor lab 2 3× hg18
Colorectal cancer [1] 1 50× hg19
SCLC [1] 1 50× hg19
We also acquired the colorectal adenocarcinoma and
SCLC data sets used in the first description of chro-
mothripsis [1] (AccessionNumber: [EGAD00001000002])
and performed our own analysis on these samples. [1]
identified chromothripsis as having occurred on chromo-
some 15 of the colorectal adenocarcinoma sample and on
chromosome 8 of the SCLC sample. Providing Shatter-
Proof with translocation and CNV calls from the colorec-
tal adenocarcinoma sample produced 5 chromothriptic
calls (4 from chromosome 15) with a median score of
0.4166 (0.174 - 0.450). See Additional file 7 for a dia-
gram of translocation and CNV calls. Similarly, when
ShatterProof was used to analyze the SV calls from the
SCLC sample, 17 chromothriptic calls were produced
(14 from chromosome 8) with a median score of 0.3196
(0.207 - 0.494). See Additional file 8 for a diagram of
translocation and CNV calls. In both cases, the highest
scoring calls identified the regions of these genomes that
were described as bearing hallmarks strongly indicative of
chromothripsis [1].
Additionally, we ran ShatterProof against 7 primary
prostate adenocarcinoma samples, which have not previ-
ously been described. ShatterProof produced an average
of 11 (9 - 13) calls per sample with a median score of
0.1437 (0.101 - 0.337). While these samples had a higher
total number of SVs than samples from other sets, a
lack of clustering of translocations and CNVs resulted in
low chromothripsis scores. To ensure the robustness of
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these results, we validated our predictions using PCR-
based analysis of the breakpoints (Additional file 9). We
also verified that similar score-distributions and conclu-
sions were obtained using diverse SV-callers (data not
shown), providing confidence that our conclusions are
independent of the SV-calling algorithm.
The results from the analysis of the prostate adenocar-
cinoma samples that had not previously been described,
demonstrates the important fact that ShatterProof pro-
duces scores which primarily reflect the organization and
clustering of SVs as opposed to simply the absolute counts
of translocations and CNVs. Figure 4 illustrates how the
chromothripsis scores that ShatterProof produces are in
fact uncorrelated with the absolute counts of transloca-
tions and CNVs.
We see in Figure 4 that ShatterProof scores are not sim-
ply a measure of the number of SVs in a sample. Rather,
the scores produced by ShatterProof reflect the extent to
which a sample exhibits the hallmarks of chromothrip-
sis. Figure 4 also demonstrates the fact that many cancer
samples with very high rates of genomic instability will
produce low scores that are similar to those of normal
samples if chromothriptic hallmarks are not discovered.
Figure 5 illustrates how the hallmark scores for the high-
est scoring region in each sample contributed to the final
score for that region.
We found that the calls ShatterProof produced for the
blood normal samples had a maximum value of 0.3667.
Figure 6 illustrates how the samples that were known
to be chromothripsis positive (prostate adenocarcinoma
samples from the LTL, colorectal adenocarcinoma sam-
ples, and the SCLC samples) all produced multiple calls
with scores that were greater than 0.37. Furthermore, it is
the case that all of these high scoring calls correctly iden-
tified regions that had been identified in other studies as
being chromothriptic.
Based on these two findings, we suggest that when run-
ning ShatterProof with the default hallmark weightings,
a call with a score that exceed 0.37 identifies a region
of the genome in which it is likely that chromothripsis
has occurred. Using this cut-off we analyzed the results
that ShatterProof produced for the 7 prostate adenocarci-
noma samples which had not been previously analyzed for
signs of chromothripsis.We found that 0 calls with a score
that exceeded 0.37 were produced. This strongly suggests
that none of these tumor samples have experienced any
chromothriptic events.
Performance
ShatterProof performance is most dependent on the
genome bin size parameter. This parameter defines the
size of bins into wich the genome is divided. A smaller
bin size will require ShatterProof to consume more
memory and cause the sliding window analysis to take
longer. Specifically, memory consumption and runtime
are inversely realted to bin size (i.e. O(1/n)). Additional
file 10 illustrates this relationship. Changing the win-
dow size or number of input lines (representing CNV,
Figure 4 CNV and translocation count vs average chromothripsis score. These plots illustrates how a high total SV count does not necessarily
produce high chromothripsis scores. Samples producing the highest chromothripsis scores had some of the lowest translocation and CNV counts,
showing that ShatterProof scores are dominated by the clustering of SVs, not the absolute counts.
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Figure 5 Hallmark scores of highest scoring region per sample. The bottom row indicates the relative weightings assigned to each hallmark via
MCA and thus the maximum possible score that can be achieved. All rows above the bottom one depict the contribution of each hallmark score to
the highest final score for a sample. Dark purple indicates high scores; white indicates low scores. The two samples expressing the TP53 hallmark
correspond to the highest scores from the 2 LTL samples.
translocation, and LOH calls) has a limited effect on per-
formance relative to changing the bin size. However, in
general, increasing the window size decreases the time
required to perform the sliding window analysis and
increasing the number of input lines increases run time
as well as memory consumption. Testing was performed
using a single core (Intel(R) Xeon(R) CPU E5540 @ 2.53
GHz) with 8 GB of physical memory. When ShatterProof
was run using the default config file supplied with the
ShatterProof distribution (Bin Size: 1000, Window Size:
10000), it consumed 670 MB of memory and its run time
was on average 60 seconds with a standard deviation of 3.5
seconds across 10 trial runs.
Discussion
Use of ShatterProof will mitigate the shortcomings of
ad hoc characterization by generating a wide range of
detailed metrics which allow for more accurate identifica-
tion and precise quantification of chromothriptic events.
ShatterProof relies on SV calls that are produced by other
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Figure 6 Final chromothripsis scores. All scores produced by ShatterProof for each sample. The gold symbols represent calls made by
ShatterProof that correspond to regions of the genomes that were previously identified in other studies as being chromothriptic. Samples
highlighted in red produced numerous calls with scores over 0.37 and as such are believed to have experienced a chromothriptic event.
tools and as such its output is dependent on the tools
chosen as well as their parameterization. Consequently,
ShatterProof scores are not directly comparable if differ-
ent tools were used to produce input data. Additionally, if
the hallmark weightings used to produce scores are differ-
ent between projects, then direct score comparisons will
be ambiguous. However, ShatterProof provides a stan-
dardized pipeline that allows researchers to quickly iden-
tify chromothripsis in large amounts of data and produce
detailed metrics which can be easily reproduced by others.
The definition of chromothripsis, including what
exactly are its hallmarks, remains controversial. At time
of writing there is no singular and clear definition of
chromothripsis, and as such ShatterProof must rely on
heuristics in order to identify chromothriptic candidates.
Realizing that the definition of chromothripsis may
change over time, we designed ShatterProof to use many
user-definable parameters so that as the definition of
chromothripsis evolves, the tool could be easily adapted
to continue to provide accurate analysis of data.
Indeed, we hope the data produced by ShatterProof will
help lead to a more detailed and concrete characteriza-
tion of chromothripsis by giving a common and exten-
sible language for describing this phenomenon. Future
development work planned for ShatterProof includes aug-
menting the scoring equations to consider the quality
values of SV calls when calculating hallmark scores. Addi-
tionally, we are investigating using machine learning to
improve the precision of identification. As sequencing of
additional chromothriptic tumours happens, training sets
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can be created and used to obviate the need for hall-
mark weightings and lead to a better characterization of
chromothriptic events.
Conclusion
The discovery of chromothripsis has revealed a new
mechanism by which cancer genomes evolve. The wide
variety of cancers in which chromothripsis occurs speaks
to the importance of further investigation. ShatterProof
accurately and efficiently annotates occurrences of chro-
mothripsis in genomic data and can easily be integrated
into existing sequence analysis pipelines. Use of Shatter-
Proof will enable researchers to quickly screen a large
number of samples and thus improve the detection rate
of chromothripsis. As the prevalence of whole-genome
sequencing increases, the need for tools such as Shat-
terProof which allow the rapid and accurate analysis of
large-scale data will continue to increase.
Availability and requirements
Project name: ShatterProof
Project home page: http://search.cpan.org/~sgovind/
Shatterproof
Operating system(s): Platform independent
Programming language: Perl
Other requirements: Perl version>5.10
License: GNU GPL v3.0
Any restrictions to use by non-academics:None
Additional files
Additional file 1: Supplementary Figure 1 - example input file
formats. Examples of the three types of input file formats that ShatterProof
reads.
Additional file 2: MCA calculationmatrix. Spreadsheet document used
to calculate hallmark weightings.
Additional file 3: Appendix. The Appendix includes a more detailed
description of the MCA process as well as a sample final report file.
Additional file 4: FREEC configuration file. Configuration file that was
used to run Control-FREEC.
Additional file 5: Supplementary Figure 2 - Clustering of SVs to
chromosome 4,8,12, and 20 of prostate adenocarcinoma genome
(LTL-1). Circos plot of prostate cancer adenocarcinoma genome (sample
LTL-1). From outermost ring going inward each ring indicates: cytogenetic
bands, genetic density, histogram of CNV locations, and link diagram of
translocation data (interchromosomal in blue, intrachromosomal in red).
The plot demonstrates clustering of structural variation to chromosomes
4,8,12, and 20.
Additional file 6: Supplementary Figure 3 - Clustering of SVs to
chromosome 4,8,12, and 20 of prostate adenocarcinoma genome
(LTL-2). Circos plot of prostate cancer adenocarcinoma genome (sample
LTL-2). From outermost ring going inward each ring indicates: cytogenetic
bands, genetic density, histogram of CNV locations, and link diagram of
translocation data (interchromosomal in blue, intrachromosomal in red).
The plot demonstrates clustering of structural variation to chromosomes
4,8,12, and 20.
Additional file 7: Supplementary Figure 4 - Clustering of SVs to
chromosome 15 of colorectal cancer genome. Circos plot of colorectal
cancer genome. From outermost ring going inward each ring indicates:
cytogenetic bands, genetic density, histogram of CNV locations, and link
diagram of translocation data (interchromosomal in blue,
intrachromosomal in red). The plot clearly demonstrates a clustering of
structural variation to chromosome 15.
Additional file 8: Supplementary Figure 5 - Clustering of SVs to
chromosome 8 of SCLC genome. Circos plot of SCLC genome. From
outermost ring going inward each ring indicates: cytogenetic bands,
genetic density, histogram of CNV locations, and link diagram of
translocation data (interchromosomal in blue, intrachromosomal in red).
The plot clearly demonstrates a clustering of structural variation to
chromosome 8.
Additional file 9: PCR validation methods and data. This document
contains the methods used to perform PCR validation on a subset of the
translocation calls presented in the paper as well as the specific primer
sequences and the validation results.
Additional file 10: Supplementary Figure 6 - Run time andmemory
consumption. These plots illustrate the inverse relationship between run
time/memory consumption and bin size. The error bars on the run time vs
bin size plot indicate the range of times that were observed across 10 trial
runs. No error bars are present on the memory consumption vs bin size
plot as we found memory consumption to be consistent between trial
runs using the same bin size.
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SV: Structural variation; CNV: Copy number variation; VCF: Variant call format;
CN: Copy number; LOH: Loss of heterozygosity; MCA: Multi-criteria analysis.
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